The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News’ Amy Maxmen has more.
This story was indexed from the original publisher.
Read at CBS News